← Open Payments lookup

GAMMAL HASSANIEN: Open Payments

NPI 1528262961 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,718 in 47 payments from 14 companies in 2025. Trend: 2023 $1,673 · 2024 $1,760 · 2025 $2,718

Food & beverage: $2,718
CompanyPaymentsAmount
Madrigal Pharmaceuticals20$1,036
AstraZeneca Pharmaceuticals LP5$397
Corcept Therapeutics4$296
Amgen Inc.2$225
ABBVIE INC.1$125
Novo Nordisk Inc1$125
Braeburn Inc.1$122
ABIOMED1$113
Bard Peripheral Vascular, Inc.1$77
Dexcom, Inc.3$65

Products named: REZDIFFRA, Korlym, AIRSUPRA, BREZTRI, MAVYRET, Ozempic, Repatha, BRIXADI.

Industry payments across NJ — which companies pay providers there.